Obetocad 5mg Tablet
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Obeticholic acid (5mg)
Overview Obetocad 5mg Tablet
Ursodeoxycholic acid (UDCA) 5mg, administered alone or concurrently with other treatments, manages primary biliary cholangitis. Its mechanism involves suppressing bile acid synthesis and accelerating their hepatic clearance, thereby mitigating liver damage. UDCA 5mg can be ingested with or without food, consistently at prescribed intervals to optimize efficacy. Treatment adherence is crucial; discontinue only upon physician guidance. Common adverse reactions may encompass pruritus, lassitude, dermatitis, pharyngitis, vertigo, bowel irregularity, arthralgia, atopic dermatitis, and thyroid dysfunction. Report persistent or worsening side effects promptly. Prior to commencing therapy, disclose existing health issues and all concurrent medications, as interactions may occur. Pregnant or lactating individuals should seek medical counsel before initiating UDCA treatment.
Uses of Obetocad 5mg Tablet
Managing primary biliary cholangitis
Major Benefits of Obetocad 5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The 5mg Obetocad tablet should be swallowed whole; do not break, crush, or chew it. While it can be taken with or without food, consistency is key—take it at the same time each day.
Common Side effects of Obetocad 5mg Tablet:
- Throat pain
- Itching
- Fatigue
- Abdominal discomfort
- Rash
- Joint pain
- Oropharyngeal pain
- Dizziness
- Constipation
- Peripheral edema
- Palpitations
- Fever
- Thyroid disorders
- Eczema
How to use Obetocad 5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 5mg Obetocad tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistency is key—choose a specific time each day.
How Obetocad 5mg Tablet works:
Obetocad 5mg tablets activate the Farnesoid X receptor (FXR), a molecule controlling bile acid production, lipid processing, and blood sugar management. By suppressing bile acid formation and boosting their excretion, Obetocad 5mg tablets lower hepatic bile acid reserves, mitigating their harmful effects. This ultimately contributes to enhanced liver health.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Obetocad 5mg Tablet may pose safety risks; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Obetocad 5mg Tablet in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Obetocad 5mg Tablet with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Obetocad 5mg Tablet on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
For individuals with kidney disease, Obetocad 5mg tablets appear to pose minimal risk. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Obetocad 5mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Obetocad 5mg Tablet :
Omit any missed 5mg Obetocad Tablet dose; resume your regular medication schedule. Avoid taking a double dose.
Facts to Know About Obetocad 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Bile acid derivatives, including alcohols and diols |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently